Local Recurrence Rate after Clear Margins in Wide Local Excision in Soft Tissue Sarcoma 2 Years after Index Surgery

Local Recurrence Following Wide Local Excision in Soft Tissue Sarcoma

Authors

  • Awais Iqbal Department of Orthopedic Surgery, Shifa International Hospital, Islamabad, Pakistan
  • Zohaib Nadeem Department of Orthopedic Surgery, Shifa International Hospital, Islamabad, Pakistan
  • Linta Masroor Shifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan
  • Sohail Hafeez Department of Orthopedic Surgery, Shifa International Hospital, Islamabad, Pakistan
  • Hasnain Ali Department of Orthopedic Surgery, Shifa International Hospital, Islamabad, Pakistan
  • Syed Muneeb Asim Department of Orthopedic Surgery, Shifa International Hospital, Islamabad, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i11.3263

Keywords:

Recurrence, Clear Margins, Soft Tissue Sarcoma

Abstract

Soft tissue sarcomas include a diverse collection of uncommon, malignant neoplasms originating in mesenchymal tissues. Recent cancer studies indicate that they comprise around 1% of all malignancies globally. Objectives:  To evaluate the incidence of local recurrence among patients who achieved clear surgical margins following wide local excision for soft tissue sarcoma. Methods: This cross-sectional retrospective study was conducted at the Orthopedic Department of Shifa International Hospital, Islamabad. Sixty patients participated in this investigation. In this investigation, patients who underwent wide local excision and attained clear surgical margins were enrolled after being diagnosed with histologically confirmed soft tissue sarcoma. Results: The study included 60 sarcoma patients (63.3% males, mean age 46.15 ± 22.74 years). Two-year recurrence occurred in 8 (13.3%) cases, mostly synovial sarcoma. Recurrence showed no significant association with histologic subtype, therapy type, surgical margin, or tumor grade (p>0.05). Conclusions: This study corroborates existing literature on the recurrence patterns of STS, emphasizing the significance of histological subtypes, comorbidities, and surgical margins in influencing patient outcomes. Continued research into the molecular underpinnings of STS and the development of targeted therapies are crucial for improving prognosis and reducing recurrence rates.

References

Paudel A, Chattopadhyay P, Rose B, Watson A, D’Amato G, Trent J, et al. Systemic Treatment in Soft Tissue Sarcomas: Are We Making a Difference?. Cancers. 2025 Mar; 17(5): 889. doi: 10.3390/cancers17050889. DOI: https://doi.org/10.3390/cancers17050889

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2024 May; 74(3): 229–63. doi: 10.3322/caac.21834. DOI: https://doi.org/10.3322/caac.21834

Ballard DH, Mazaheri P, Oppenheimer DC, Lubner MG, Menias CO, Pickhardt PJ, et al. Imaging of Abdominal Wall Masses, Masslike Lesions, and Diffuse Processes. Radiographics. 2020 May; 40(3): 684–706. doi: 10.1148/rg.2020190170. DOI: https://doi.org/10.1148/rg.2020190170

García-Ortega DY, Clara-Altamirano MA, Martín-Tellez KS, Caro-Sánchez CH, Álvarez-Cano A, Lino-Silva LS, et al. Epidemiological Profile of Soft Tissue Sarcomas of the Extremities: Incidence, Histological Subtypes, and Primary Sites. Journal of Orthopedics. 2021 May; 25: 70–4. doi: 10.1016/j.jor.2021.03.021. DOI: https://doi.org/10.1016/j.jor.2021.03.021

Debuquoy C, Romeo C, Vanacker H, Ray-Coquard I. Rare Ovarian Tumors: An Update on Diagnosis and Treatment. International Journal of Gynecological Cancer. 2020 Jun; 30(6): 879–87. doi: 10.1136/ijgc-2020-001235. DOI: https://doi.org/10.1136/ijgc-2020-001235

Wittenberg S, Paraskevaidis M, Jarosch A, Flörcken A, Brandes F, Striefler J, et al. Surgical Margins in Soft Tissue Sarcoma Management and Corresponding Local and Systemic Recurrence Rates: A Retrospective Study Covering 11 Years and 169 Patients in a Single Institution. Life. 2022 Oct; 12(11): 1694. doi: 10.3390/life12111694.

Sambri A, Caldari E, Fiore M, Zucchini R, Giannini C, Pirini MG, et al. Margin Assessment in Soft Tissue Sarcomas: Review of the Literature. Cancers. 2021 Apr; 13(7): 1687. doi: 10.3390/cancers13071687. DOI: https://doi.org/10.3390/cancers13071687

Wittenberg S, Paraskevaidis M, Jarosch A, Flörcken A, Brandes F, Striefler J, et al. Surgical Margins in Soft Tissue Sarcoma Management and Corresponding Local and Systemic Recurrence Rates: A Retrospective Study Covering 11 Years and 169 Patients in a Single Institution. Life. 2022 Oct; 12(11): 1694. doi: 10.3390/life12111694. DOI: https://doi.org/10.3390/life12111694

Osterloh J, Ludolph I, Grützmann R, Meyer A, Lang W, Horch RE, et al. Interdisciplinary Surgical Therapy of Extremity Soft-Tissue Sarcomas: A Personalized Resection and Reconstruction Algorithm. Journal of Personalized Medicine. 2023 Jan; 13(2): 262. doi: 10.3390/jpm13020262. DOI: https://doi.org/10.3390/jpm13020262

Fatima S, Akhlaque R, Nasrullah M, Amin M, Imdad S, Imran M, et al. Evaluation of Surgical Resection and Reconstruction Outcomes in Patients with Various Histological Subtypes of Soft Tissue Sarcomas: A Prospective Cohort Analysis. Pakistan Journal of Health Sciences. 2024 Jun; 5(6): 199–205. doi: 10.54393/pjhs.v5i06.1689. DOI: https://doi.org/10.54393/pjhs.v5i06.1689

Hayes AJ, Nixon IF, Strauss DC, Seddon BM, Desai A, Benson C, et al. UK Guidelines for the Management of Soft Tissue Sarcomas. British Journal of Cancer. 2025 Jan; 132(1): 11–31. doi: 10.1038/s41416-024-02674-y. DOI: https://doi.org/10.1038/s41416-024-02674-y

Potkrajcic V, Kolbenschlag J, Sachsenmaier S, Daigeler A, Ladurner R, Golf A, et al. Postoperative Complications and Oncologic Outcomes after Multimodal Therapy of Localized High Risk Soft Tissue Sarcoma. Radiation Oncology. 2022 Dec; 17(1): 210. doi: 10.1186/s13014-022-02166-4. DOI: https://doi.org/10.1186/s13014-022-02166-4

Muehlhofer HM, Schlossmacher B, Lenze U, Lenze F, Burgkart R, Gersing AS, et al. Oncological Outcome and Prognostic Factors of Surgery for Soft Tissue Sarcoma after Neoadjuvant or Adjuvant Radiation Therapy: A Retrospective Analysis over 15 Years. Anticancer Research. 2021 Jan; 41(1): 359–68. doi: 10.21873/anticanres.14784. DOI: https://doi.org/10.21873/anticanres.14784

Ebrahimpour A, Chehrassan M, Sadighi M, Karimi A, Looha MA, Kafiabadi MJ, et al. Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis according to National Population-Based Study. Archives of Bone and Joint Surgery. 2022 Jan; 10(1): 67.

Motanya JB and Saidi H. Recurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas. Annals of African Surgery. 2013 Sep; 10(2).

Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic Type: An Independent Prognostic Factor in Primary Soft Tissue Sarcoma of the Extremity?. Annals of Surgical Oncology. 2003 May; 10(4): 432–40. doi: 10.1245/ASO.2003.05.014. DOI: https://doi.org/10.1245/ASO.2003.05.014

Gökçe K, Doğan D, Karadayı AN, Midi A. Recurrent Malignant Fibrous Histiocytoma of the Forearm: A Rare Soft Tissue Sarcoma. Journal of Surgery and Medicine. 2024 Dec; 8(12): 207–10. doi: 10.28982/josam.7873. DOI: https://doi.org/10.28982/josam.7873

Gutierrez JC, Perez EA, Franceschi D, Moffat FL Jr, Livingstone AS, Koniaris LG, et al. Outcomes for Soft-Tissue Sarcoma in 8249 Cases from a Large State Cancer Registry. Journal of Surgical Research. 2007 Jul; 141(1): 105–14. doi: 10.1016/j.jss.2007.02.026. DOI: https://doi.org/10.1016/j.jss.2007.02.026

Eilber FR, Eckardt J, et al. Surgical Management of Soft Tissue Sarcomas. Seminars in Oncology. 1997 Oct; 24(5): 526–33.

Ghanaati S, Udeabor SE, Winter A, Sader R, Heselich A. Cancer Recurrence in Operated Primary Oral Squamous Cell Carcinoma Patients Seems to Be Independent of the Currently Available Postoperative Therapeutic Approach: A Retrospective Clinical Study. Current Oncology. 2025 Apr; 32(4): 208. doi: 10.3390/curroncol32040208. DOI: https://doi.org/10.3390/curroncol32040208

Lin JS, Coleman L, Voskuil RT, Malik A, Mayerson JL, Scharschmidt TJ, et al. Local Recurrence Rates of Superficial versus Deep Soft Tissue Sarcoma. Archives of Orthopaedic and Trauma Surgery. 2024 Jul; 144(7): 2967–73. doi: 10.1007/s00402-024-05326-1. DOI: https://doi.org/10.1007/s00402-024-05326-1

Gonzalez MR, Mendez-Guerra C, Goh MH, Pretell-Mazzini J. Principles of Surgical Treatment of Soft Tissue Sarcomas. Cancers. 2025 Jan; 17(3): 401. doi: 10.3390/cancers17030401. DOI: https://doi.org/10.3390/cancers17030401

Downloads

Published

2025-11-30
CITATION
DOI: 10.54393/pjhs.v6i11.3263
Published: 2025-11-30

How to Cite

Iqbal, A., Nadeem, Z., Masroor, L., Hafeez, S., Ali, H., & Asim, S. M. (2025). Local Recurrence Rate after Clear Margins in Wide Local Excision in Soft Tissue Sarcoma 2 Years after Index Surgery: Local Recurrence Following Wide Local Excision in Soft Tissue Sarcoma. Pakistan Journal of Health Sciences, 6(11), 43–47. https://doi.org/10.54393/pjhs.v6i11.3263

Issue

Section

Original Article

Plaudit